In contrast, P53 (Cance and Golubovskaya, 2008) and ATF3 (Tian et al., 2021) limit some of the tumor’s functions by lowering the activity of the PTK2 promoter and the number of transcripts. This evidence concerns the gene PTK2 and neoplasm.